医薬品材料品質管理戦略に向けた分析測定不確かさの適用と考察
Michael A Zompa1, Dolee Merai1, Paul Oram1
1Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
Abstract:
Guidance documents ICH Q14 and USP <1220> discuss the uncertainty associated with measurements and its impact on decisions regarding pharmaceutical materials. Through case studies, we demonstrate an approach for setting acceptance limits for analytical test results accommodating analytical measurement uncertainty, establishing an integrated control strategy, and reinforcing confidence around material quality.
関連する概念動画
Uncertainty in Measurement: Accuracy and Precision
Uncertainty: Overview
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Data Validation
Key parameters for method validation include:
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Uncertainty in Measurement: Reading Instruments


